Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded
Renée A. Douma(Amsterdam UMC Location University of Amsterdam), Marc Righini(Service de la Santé Publique), Shannon M. Bates(Thrombosis and Atherosclerosis Research Institute), Grégoire Le Gal(University of Ottawa), Marc Carrier, Roger E. G. Schutgens(Utrecht University), Arnaud Perrier(University Hospital of Geneva), H Bounameaux(Service de la Santé Publique), Douwe H. Biesma(Utrecht University), Pieter W. Kamphuisen(University Medical Center Groningen), Cristina Legnani(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Jeffrey S. Ginsberg(McMaster University), Gualtiero Palareti(Policlinico S.Orsola-Malpighi), Minkang Tan(Leiden University Medical Center), Gerben C. Mol(Diakonessenhuis hospital)
Cited by 130
Related Papers
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Oral Anticoagulant Therapy
|CHEST Journal|2012|1.5k
Increased fetal loss in women with heritable thrombophilia
|The Lancet|1996|677
Diagnosis of DVT
|CHEST Journal|2012|676
Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.
|Bristol Research (University of Bristol)|2021|589